Total Funding
11
Total FundingSeries A raised
Growth Score
pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
184739
Upside is developing the most advanced and best treatment for severe burns
Rod Dunbar: Chief Scientific Officer- Robert Feldman: Chief Executive OfficerPast Role: COVID-19 Vaccine Corporation, CEO
About the Company
Upside is developing the most advanced and best treatment for severe burns. The Upside product is a regenerative medicine solution to current shortcomings in the current treatment of severe burns patients. Upside will take a small sample of unburnt patient skin and grow it into differentiated, graftable skin in order to cover the patient’s own
burns. Product advantages are that Upside's engineered skin is produced faster than any competitive pipeline product, it is supplied in bigger sheets and has good handling characteristics. Upside has intellectual property covering the processes conferring these specific advantages.
